International Research Congress

Home / International Research Congress
2025-Amsterdam-IRC-Conference-Banner-FINAL-V2

Join us for the 2025 International Research Congress in Amsterdam, the Netherlands, EU.

Deadline for In-Person Conference Registration: May 15, 2025

Preliminary Agenga Available: Click Here

We are pleased to announce the 2025 International Research Congress will take place June 12-13 in Amsterdam and online. Please use the above buttons to register*, book your hotel room, submit posters, and apply for scholarships.

Abstract submissions for the 2025 International Research Congress are closed. Researchers and clinicians specializing in FSHD and related fields are encouraged to participate. You can still submit an late-breaking poster submission.

The FSHD Society is offering a limited number of scholarships to cover the cost of registration and 2 nights’ hotel accommodation (for those attending in-person). Scholarship applications are closed.

*Refund policy: Registrations canceled on or before May 1st, 2025 will receive a full refund. No refunds will be given after May 1, 2025.

2025 Young Investigator Award

We invite you to submit nominations for the 2025 FSHD Society Young Investigator Award, which recognizes a junior researcher who shows exceptional promise. Qualifications for nominations may include any postdoctoral trainees, clinical fellows and junior faculty establishing their first independent laboratory (less than 5 years).
Please provide the following information about your nominee:

  • Nominee's full name
  • Nominee's current title and institution
  • Nominee's CV or biography
  • Brief statement (200 words) describing why your nominee is deserving of the award.
  • Key peer-reviewed publications (no more than 3)
  • Please submit your nomination by May 15.
  • Email nominations to: fshdmeetings@fshdsociety.org

The FSHD Society’s annual FSHD International Research Congress is the premier global conference exclusively focused on facioscapulohumeral muscular dystrophy (FSHD) research.

With the recent advances in FSHD research and clinical advances, this conference has become catalytic in translating ideas into potential therapies.

World renowned clinicians, medical researchers, pharmaceutical industry leaders and basic scientists present and discuss new developments, reinforce collaborative efforts, facilitate new initiatives, and coordinate research and clinical activities.

Our 2024 Congress in Denver, Colorado drew more than 230 attendees including more than 50 from industry.

Thank you to our generous sponsors!

IRC-2025-sponsor-logos-4-3-25-1

Programs and abstracts of past meetings